Skip to content
WeighLab
Menu

Head-to-head · Cost-Efficiency Index

Ro vs PlexusDx

Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.

Better valueGrade B · #22

Ro

People who need brand-name (Wegovy/Zepbound) access or insurance navigation and will accept price opacity for it.

Visit Ro
VS
Grade B− · #27

PlexusDx

Shoppers who want a published starting price with an oral semaglutide option, all 50 states.

Visit PlexusDx

The verdict

Winner · RoGrade B vs B−

Ro takes it, leading the Cost-Efficiency Index 84 to 82. The widest formulary — brand-name and oral access, with a named CMO — but the $149/mo (or $74/mo prepaid annual) membership fee is separate from the drug's own opaque, insurance-dependent price. PlexusDx still earns a B−Shoppers who want a published starting price with an oral semaglutide option, all 50 states.

Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Ro.

Factor by factor

Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.

Normalized Cost/Month

74
88

Price Transparency

72
94

Nationwide Access

85
86

Formulation Options

93
77

Clinical Oversight

90
74

Contract Flexibility

84
55

Pricing, coverage & formulary

The disclosed facts behind the scores. Lower price wins its row (teal).

SpecRoPlexusDx
Cost-Efficiency Index84/10082/100
Semaglutide / moNot disclosed (drug); $149/mo Ro Body membership separately$149/mo (all doses, compounded)
Tirzepatide / moNot disclosed (drug); $149/mo Ro Body membership separately$249/mo (all doses, compounded)
Semaglutide / yr (modeled)$1,788
Tirzepatide / yr (modeled)$2,988
CoverageMulti-stateAll 50 states
Oral / sublingualYesYes
Brand-name accessYesCompounded only
Rank here#22#27

Ro

84/100

Where the value is

  • Brand-name access and a dedicated insurance concierge to help navigate drug coverage
  • Oral options (including the newer Foundayo/orforglipron pill) widen the formulary
  • Named, credentialed Chief Medical Officer (Dr. Melynda Barnes, MD) and a public LegitScript certificate (#3722005)

The tradeoffs

  • Does not publish compounded pricing up front — a blind spot in any cost model
  • The $74/mo membership figure often quoted requires a full year prepaid upfront; month-to-month membership billing is $149/mo, and the drug cost is a separate charge on top of either
Visit Ro

Full Ro review →

PlexusDx

82/100

Where the value is

  • LegitScript Certified, stated directly on the homepage
  • Both injection and oral tablet formats for semaglutide from the same starting price
  • All 50 states served

The tradeoffs

  • 'Starts at' pricing — the page does not disclose what higher doses cost, so $149/$249 is a floor, not what most patients settling into a maintenance dose will pay
  • No named prescriber, medical director, or specific compounding pharmacy
Visit PlexusDx

Full PlexusDx review →

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.

Keep comparing

← All head-to-head comparisons